Ketone supplementation decreases tumor cell viability and prolongs survival of mice with metastatic cancer

International Journal of Cancer

Volumn 135, Issue 7, 2014, Pages 1711-1720

  Poff, A M ^a   Ari, C ^a   Arnold, P ^b   Seyfried, T N ^c   D'Agostino, D P ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b Savind Inc   (United States)

^c BOSTON COLLEGE   (United States)

Author keywords

ketone; metastasis; Warburg effect

Indexed keywords

1,3 BUTANEDIOL; 3 HYDROXYBUTYRIC ACID; ACETOACETIC ACID; GLUCOSE; KETONE; KETONE BODY;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BIOLUMINESCENCE; BODY WEIGHT; CALORIC RESTRICTION; CANCER GROWTH; CANCER SURVIVAL; CELL CULTURE; CELL GROWTH; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DISEASE COURSE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; GENE MUTATION; GLUCOSE BLOOD LEVEL; GLUCOSE INTAKE; GROWTH RATE; IN VITRO STUDY; IN VIVO STUDY; MALE; METASTASIS; MOUSE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SURVIVAL TIME; TUMOR CELL; TUMOR GROWTH; WALKER WARBURG SYNDROME;

KETONE; METASTASIS; WARBURG EFFECT;

ANIMALS; APOPTOSIS; BLOOD GLUCOSE; BODY WEIGHT; BRAIN NEOPLASMS; CELL PROLIFERATION; DIETARY SUPPLEMENTS; HUMANS; KETONES; LUMINESCENT MEASUREMENTS; MALE; MICE; SURVIVAL RATE; TUMOR CELLS, CULTURED;

EID: 84904438541     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.28809     Document Type: Article

References (52)

1. Seyfried TN, Shelton LM,. Cancer as a metabolic disease. Nutr Metab (Lond) 2010; 7: 7.
2. Shelton LM, Huysentruyt LC, Mukherjee P, et al. Calorie restriction as an anti-invasive therapy for malignant brain cancer in the VM mouse. ASN Neuro 2010; 2: e00038.
3. Mavropoulos J, Buschemeyer W, Tewari A, et al. The effects of varying dietary carbohydrate and fat content on survival in a murine LNCaP prostate cancer xenograft model. Cancer Prev Res (Phil) 2009; 2: 557-65.
4. Zuccoli G, Marcello N, Pisanello A, et al. Metabolic management of glioblastoma multiforme using standard therapy together with a restricted ketogenic diet: case Report. Nutr Metab (Lond) 2010; 7: 33.
5. Nebeling LC, Miraldi F, Shurin SB, et al. Effects of a ketogenic diet on tumor metabolism and nutritional status in pediatric oncology patients: two case reports. J Am Coll Nutr 1995; 14: 202-8.
6. Magee BA, Potezny N, Rofe AM, et al. The inhibition of malignant cell growth by ketone bodies. Aust J Exp Biol Med Sci 1979; 57: 529-39.
7. Wheatley KE, Williams EA, Smith NC, et al. Low-carbohydrate diet versus caloric restriction: effects on weight loss, hormones, and colon tumor growth in obese mice. Nutr Cancer 2008; 60: 61-8.
8. Rossifanelli F, Franchi F, Mulieri M, et al. Effect of energy substrate manipulation on tumor-cell proliferation in parenterally fed cancer-patients. Clin Nutr 1991; 10: 228-32.
9. Poff AM, Ari C, Seyfried TN, et al. The ketogenic diet and hyperbaric oxygen therapy prolong survival in mice with systemic metastatic cancer. PLoS One 2013; 8: e65522.
10. Fine E, Segal-Isaacson C, Feinman R, et al. Targeting insulin inhibition as a metabolic therapy in advanced cancer: a pilot safety and feasibility dietary trial in 10 patients. Nutrition 2012; 28: 1028-35.
11. Fine E, Miller A, Quadros E, et al. Acetoacetate reduces growth and ATP concentration in cancer cell lines which over-express uncoupling protein 2. Cancer Cell Int 2009; 9: 14.
12. Skinner R, Trujillo A, Ma X, et al. Ketone bodies inhibit the viability of human neuroblastoma cells. J Pediatr Surg 2009; 44: 212.
13. Veech RL, Chance B, Kashiwaya Y, et al. Ketone bodies, potential therapeutic uses. IUBMB Life 2001; 51: 241-7.
14. Isidoro A, Martínez M, Fernández P, et al. Alteration of the bioenergetic phenotype of mitochondria is a hallmark of breast, gastric, lung and oesophageal cancer. Biochem J 2004; 378 (Part 1): 17-20.
15. Kiebish MA, Han X, Cheng H, et al. Brain mitochondrial lipid abnormalities in mice susceptible to spontaneous gliomas. Lipids 2008; 43: 951-9.
16. Kiebish MA, Han X, Seyfried TN,. Examination of the brain mitochondrial lipidome using shotgun lipidomics. Methods Mol Biol 2009; 579: 3-18.
17. Arismendi-Morillo G, Castellano-Ramirez A,. Ultrastructural mitochondrial pathology in human astrocytic tumors: potentials implications pro-therapeutics strategies. J Electron Microsc 2008; 57: 33-42.
18. Kiebish MA, Han X, Cheng H, et al. Cardiolipin and electron transport chain abnormalities in mouse brain tumor mitochondria: lipidomic evidence supporting the Warburg theory of cancer. J Lipid Res 2008; 49: 2545-56.
19. Modica-Napolitano J, Singh K,. Mitochondrial dysfunction in cancer. Mitochondrion 2004; 4: 755-817.
20. Seyfried TN,. Cancer as a metabolic disease: on the origin, management, and prevention of cancer. Hoboken, NJ: Wiley, 2012.
21. Maurer G, Brucker D, Bähr O, et al. Differential utilization of ketone bodies by neurons and glioma cell lines: a rationale for ketogenic diet as experimental glioma therapy. BMC Cancer 2011; 11: 315.
22. Wu GY, Thompson JR,. The effect of ketone bodies on alanine and glutamine metabolism in isolated skeletal muscle from the fasted chick. Biochem J 1988; 255: 139-44.
23. Schumacker P,. Reactive oxygen species in cancer cells: live by the sword, die by the sword. Cancer Cell 2006; 10: 175-81.
24. Dhup S, Dadhich RK, Porporato PE, et al. Multiple biological activities of lactic acid in cancer: influences on tumor growth, angiogenesis and metastasis. Curr Pharm Des 2012; 18: 1319-30.
25. Shimazu T, Hirschey M, Newman J, et al. Suppression of oxidative stress by β-hydroxybutyrate, an endogenous histone deacetylase inhibitor. Science 2013; 339: 211-14.
26. Ropero S, Esteller M,. The role of histone deacetylases (HDACs) in human cancer. Mol Oncol 2007; 1: 19-25.
27. Gupta G, Massagué J,. Cancer metastasis: building a framework. Cell 2006; 127: 679-95.
28. Huysentruyt LC, Mukherjee P, Banerjee D, et al. Metastatic cancer cells with macrophage properties: evidence from a new murine tumor model. Int J Cancer 2008; 123: 73-84.
29. Shelton LM, Mukherjee P, Huysentruyt LC, et al. A novel pre-clinical in vivo mouse model for malignant brain tumor growth and invasion. J Neurooncol 2010; 99: 165-76.
30. Huysentruyt L, Akgoc Z, Seyfried T,. Hypothesis: are neoplastic macrophages/microglia present in glioblastoma multiforme? ASN Neuro 2011; 3: 183-93.
31. Huysentruyt LC, Shelton LM, Seyfried TN,. Influence of methotrexate and cisplatin on tumor progression and survival in the VM mouse model of systemic metastatic cancer. Int J Cancer 2010; 126: 65-72.
32. Kies C, Tobin RB, Fox HM, et al. Utilization of 1,3-butanediol and nonspecific nitrogen in human adults. J Nutr 1973; 103: 1155-63.
33. Mehlman M, Veech R,. Redox and phosphorylation states and metabolite concentrations in frozen clamped livers of rats fed diets containing 1,3-butanediol and DL-carnitine. J Nutr 1972; 102: 45-51.
34. D'Agostino DP, Pilla R, Held HE, et al. Therapeutic ketosis with ketone ester delays central nervous system oxygen toxicity seizures in rats. Am J Physiol Regul Integr Comp Physiol 2013; 304: R829-R836.
35. Rossi R, Dorig S, Del Prete E, et al. Suppression of feed intake after parenteral administration of D-beta-hydroxybutyrate in pygmy goats. J Vet Med A Physiol Pathol Clin Med 2000; 47: 9-16.
36. Hursting S, Smith S, Lashinger L, et al. Calories and carcinogenesis: lessons learned from 30 years of calorie restriction research. Carcinogenesis 2010; 31: 83-9.
37. Lim E, Modi KD, Kim J,. In vivo bioluminescent imaging of mammary tumors using IVIS spectrum. J Vis Exp 2009; 26: e1210, doi: 10.3791/1210.
38. Lim E, Modi K, Christensen A, Meganck J, Oldfield S, Zhang N,. Monitoring tumor metastases and osteolytic lesions with bioluminescence and micro CT imaging. J Vis Exp 2011; 50. http://www.jove.com/details.php?id=2775, doi: 10.3791/2775.
39. Arase K, Fisler JS, Shargill NS, et al. Intracerebroventricular infusions of 3-OHB and insulin in a rat model of dietary obesity. Am J Physiol 1988; 255 (6 Part 2): R974-R981.
40. Carpenter RG, Grossman SP,. Plasma fat metabolites and hunger. Physiol Behav 1983; 30: 57-63.
41. Kashiwaya Y, Pawlosky R, Markis W, et al. A ketone ester diet increases brain malonyl-CoA and Uncoupling proteins 4 and 5 while decreasing food intake in the normal Wistar Rat. J Biol Chem 2010; 285: 25950-6.
42. Amiel SA, Archibald HR, Chusney G, et al. Ketone infusion lowers hormonal responses to hypoglycaemia: evidence for acute cerebral utilization of a non-glucose fuel. Clin Sci (Lond) 1991; 81: 189-94.
43. Westman EC, Feinman RD, Mavropoulos JC, et al. Low-carbohydrate nutrition and metabolism. Am J Clin Nutr 2007; 86: 276-84.
44. Berrigan D, Perkins S, Haines D, et al. Adult-onset calorie restriction and fasting delay spontaneous tumorigenesis in p53-deficient mice. Carcinogenesis 2002; 23: 817-22.
45. Mukherjee P, Abate LE, Seyfried TN,. Antiangiogenic and proapoptotic effects of dietary restriction on experimental mouse and human brain tumors. Clin Cancer Res 2004; 10: 5622-9.
46. Seyfried B, Kiebish M, Marsh J, et al. Targeting energy metabolism in brain cancer through calorie restriction and the ketogenic diet. J Cancer Res Ther 2009; 5 (Suppl 1): 15.
47. Martinez-Outschoorn UE, Lin Z, Whitaker-Menezes D, et al. Ketone body utilization drives tumor growth and metastasis. Cell Cycle 2012; 11: 3964-71.
48. Bonuccelli G, Tsirigos A, Whitaker-Menezes D, et al. Ketones and lactate "fuel" tumor growth and metastasis: evidence that epithelial cancer cells use oxidative mitochondrial metabolism. Cell Cycle 2010; 9: 3506-14.
49. Tisdale M, Brennan R,. Loss of acetoacetate coenzyme A transferase activity in tumours of peripheral tissues. Br J Cancer 1983; 47: 293-7.
50. Marsh J, Mukherjee P, Seyfried T,. Drug/diet synergy for managing malignant astrocytoma in mice: 2-deoxy-D-glucose and the restricted ketogenic diet. Nutr Metab (Lond) 2008; 5: 33.
51. Abdelwahab M, Fenton K, Preul M, et al. The ketogenic diet is an effective adjuvant to radiation therapy for the treatment of malignant glioma. PLoS One 2012; 7: e36197.
52. Maalouf M, Rho J, Mattson M,. The neuroprotective properties of calorie restriction, the ketogenic diet, and ketone bodies. Brain Res Rev 2009; 59: 293-315.